We showed that the restoration of VentX expression in NSCLC-TAMs reverts immune landscape of NSCLC-TME and promotes the tumoricidal effects of PD-1 antibody on NSCLC cells about 4-fold but does not alter its cytocidal effects on normal lung epithelial cells. Here, VENTX is linked to non-small cell lung carcinoma.